Steroid Induced Avascular Necrosis of the Femoral Head after COVID-19 Disease and Treatment Options Including Free Vascularized Fibula Reconstruction

O. Orman, Hakan Ertem, Ethem nkar, kahraman rk
{"title":"Steroid Induced Avascular Necrosis of the Femoral Head after COVID-19 Disease and Treatment Options Including Free Vascularized Fibula Reconstruction","authors":"O. Orman, Hakan Ertem, Ethem nkar, kahraman rk","doi":"10.5455/handmicrosurg.98242","DOIUrl":null,"url":null,"abstract":"The COVID-19 pandemic caused serious mortality and morbidity all over the world. SARS-CoV-2 infection can involve several different organ systems. Osteonecrosis has been reported in the femoral head of patients treated with corticosteroids due to COVID-19 similar to SARS-COV (severe acute respiratory syndrome) endemic in 2003. Being a tertiary hospital for osteonecrosis of femoral head (ONFH) for our country, we retrospectively analyzed OFNH patients for steroid administration for COVID-19 infection. Ten male and a female, mean age 38.7, total eleven patients (16 hips) who were treated with corticosteroids due to COVID-19 disease and had ONFH were found. Four of 11 patients were medical doctors. Cumulative dose of methylprednisolone in these patients was 1964.5 (+/-1083.2) mg. The mean daily dose of methylprednisolone was 289.4 (+/-182.6) mg. Free vascularized fibula reconstruction in 8 hips, core decompression in 3 hips and conservative treatment in 5 hips were done. Overall, visual analogue scale score for pain was decreased 2.9 points, Harris Hip score were increased 14.6 points and total hip range of motion were increased 45 degrees. The COVID-19 pandemic is an ongoing issue, and avascular necrosis of the femoral head should be considered in patients who present with hip pain at the late period after COVID-19.","PeriodicalId":31023,"journal":{"name":"Hand and Microsurgery","volume":"156 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hand and Microsurgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5455/handmicrosurg.98242","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The COVID-19 pandemic caused serious mortality and morbidity all over the world. SARS-CoV-2 infection can involve several different organ systems. Osteonecrosis has been reported in the femoral head of patients treated with corticosteroids due to COVID-19 similar to SARS-COV (severe acute respiratory syndrome) endemic in 2003. Being a tertiary hospital for osteonecrosis of femoral head (ONFH) for our country, we retrospectively analyzed OFNH patients for steroid administration for COVID-19 infection. Ten male and a female, mean age 38.7, total eleven patients (16 hips) who were treated with corticosteroids due to COVID-19 disease and had ONFH were found. Four of 11 patients were medical doctors. Cumulative dose of methylprednisolone in these patients was 1964.5 (+/-1083.2) mg. The mean daily dose of methylprednisolone was 289.4 (+/-182.6) mg. Free vascularized fibula reconstruction in 8 hips, core decompression in 3 hips and conservative treatment in 5 hips were done. Overall, visual analogue scale score for pain was decreased 2.9 points, Harris Hip score were increased 14.6 points and total hip range of motion were increased 45 degrees. The COVID-19 pandemic is an ongoing issue, and avascular necrosis of the femoral head should be considered in patients who present with hip pain at the late period after COVID-19.
新型冠状病毒病后类固醇诱导的股骨头缺血性坏死及包括游离带血管的腓骨重建在内的治疗方案
新冠肺炎大流行在全球范围内造成了严重的死亡率和发病率。SARS-CoV-2感染可涉及几个不同的器官系统。据报道,因COVID-19(类似于2003年流行的SARS-COV(严重急性呼吸系统综合征))而接受皮质类固醇治疗的患者股骨头出现骨坏死。作为我国三级医院的股骨头坏死(ONFH),我们回顾性分析了OFNH患者对COVID-19感染的类固醇治疗情况。发现因COVID-19疾病接受皮质类固醇治疗并患有ONFH的患者共11例(16髋),男10例,女1例,平均年龄38.7岁。11名病人中有4名是医生。这些患者的甲基强的松龙累积剂量为1964.5 (+/-1083.2)mg。甲基强的松龙的平均每日剂量为289.4 (+/-182.6)mg。游离带血管腓骨重建术8例,核心减压术3例,保守治疗5例。总体而言,疼痛视觉模拟评分降低2.9分,Harris髋关节评分增加14.6分,髋关节总活动范围增加45度。COVID-19大流行是一个持续的问题,在COVID-19后后期出现髋关节疼痛的患者应考虑股骨头缺血性坏死。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
21
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信